Avantor Inc
AVTR13.070USD
-0.465-3.43%
Close 06/13, 16:00（ET）Quotes delayed by 15 min
8.91BMarket Cap
12.52P/E TTM
More Details of Avantor Inc Company
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Company Info
Ticker SymbolAVTR
Company nameAvantor Inc
IPO dateMay 17, 2019
Founded at2017
CEOMr. Michael Stubblefield
Number of employees13500
Security typeOrdinary Share
Fiscal year-endMay 17
Address- -
City- -
Stock exchangeNYSE Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolAVTR
IPO dateMay 17, 2019
Founded at2017
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Stubblefield
Mr. Michael Stubblefield
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.78M
-1.11%
Mr. James (Jim) Bramwell
Mr. James (Jim) Bramwell
Executive Vice President - Sales and Customer Excellence
Executive Vice President - Sales and Customer Excellence
425.12K
+29.52%
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
201.96K
+416.65%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.74K
+246.29%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
140.58K
+76.82%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%
Dr. Michael E. Severino, M.D.
Dr. Michael E. Severino, M.D.
Independent Director
Independent Director
52.07K
+48.89%
Ms. Lan Kang
Ms. Lan Kang
Independent Director
Independent Director
43.84K
+63.95%
Ms. Kitty Sahin
Ms. Kitty Sahin
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
42.27K
-8.51%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Stubblefield
Mr. Michael Stubblefield
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.78M
-1.11%
Mr. James (Jim) Bramwell
Mr. James (Jim) Bramwell
Executive Vice President - Sales and Customer Excellence
Executive Vice President - Sales and Customer Excellence
425.12K
+29.52%
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
201.96K
+416.65%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.74K
+246.29%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
140.58K
+76.82%
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Proprietary materials & consumables
3.62B
53.29%
Third party materials & consumables
3.17B
46.71%
By RegionUSD
Name
Revenue
Proportion
United States
3.55B
52.33%
All other countries
3.23B
47.67%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Proprietary materials & consumables
3.62B
53.29%
Third party materials & consumables
3.17B
46.71%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Dodge & Cox
14.71%
The Vanguard Group, Inc.
9.48%
BlackRock Institutional Trust Company, N.A.
8.22%
T. Rowe Price Investment Management, Inc.
6.16%
Barrow Hanley Global Investors
4.44%
Other
56.98%
Shareholders
Shareholders
Proportion
Dodge & Cox
14.71%
The Vanguard Group, Inc.
9.48%
BlackRock Institutional Trust Company, N.A.
8.22%
T. Rowe Price Investment Management, Inc.
6.16%
Barrow Hanley Global Investors
4.44%
Other
56.98%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
46.55%
Investment Advisor
44.13%
Hedge Fund
2.54%
Pension Fund
2.33%
Private Equity
2.06%
Research Firm
1.60%
Bank and Trust
1.42%
Family Office
1.39%
Individual Investor
1.37%
Institutional Shareholding
Updated: Mon, Jan 20
Updated: Mon, Jan 20
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
1137
703.17M
103.19%
-68.44M
2024Q4
1156
702.95M
103.24%
-73.39M
2024Q3
1145
700.88M
103.10%
-38.62M
2024Q2
1147
666.63M
98.14%
-52.63M
2024Q1
1136
657.58M
96.83%
-81.17M
2023Q4
1152
657.17M
97.18%
-48.15M
2023Q3
1143
643.33M
95.20%
-49.55M
2023Q2
1149
625.74M
92.71%
-61.95M
2023Q1
1138
629.07M
93.23%
-29.97M
2022Q4
1103
608.41M
90.30%
-53.60M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Dodge & Cox
99.15M
14.55%
+30.73M
+44.91%
Dec 31, 2024
The Vanguard Group, Inc.
63.68M
9.34%
+1.22M
+1.96%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
55.40M
8.13%
+1.68M
+3.13%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
41.36M
6.07%
-25.74M
-38.36%
Dec 31, 2024
Barrow Hanley Global Investors
30.53M
4.48%
+8.94M
+41.39%
Dec 31, 2024
State Street Global Advisors (US)
23.31M
3.42%
+939.14K
+4.20%
Dec 31, 2024
Janus Henderson Investors
18.14M
2.66%
+443.50K
+2.51%
Dec 31, 2024
1832 Asset Management L.P.
9.55M
1.4%
+497.69K
+5.50%
Dec 31, 2024
Manulife Investment Management (North America) Limited
9.16M
1.34%
+2.98M
+48.32%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
John Hancock Fundamental All Cap Core ETF
1.93%
First Trust Health Care Alphadex Fund
1.49%
Otter Creek Focus Strategy ETF
1.29%
BNY Mellon Women's Opportunities ETF
0.95%
Amplify AI Powered Equity ETF
0.73%
Vanguard S&P Mid-Cap 400 Value Index Fund
0.68%
SPDR S&P 400 Mid Cap Value ETF
0.68%
iShares S&P Mid-Cap 400 Value ETF
0.66%
First Trust Large Cap Value Alphadex Fund
0.59%
Pacer Trendpilot US Mid Cap ETF
0.39%
View more
John Hancock Fundamental All Cap Core ETF
Proportion1.93%
First Trust Health Care Alphadex Fund
Proportion1.49%
Otter Creek Focus Strategy ETF
Proportion1.29%
BNY Mellon Women's Opportunities ETF
Proportion0.95%
Amplify AI Powered Equity ETF
Proportion0.73%
Vanguard S&P Mid-Cap 400 Value Index Fund
Proportion0.68%
SPDR S&P 400 Mid Cap Value ETF
Proportion0.68%
iShares S&P Mid-Cap 400 Value ETF
Proportion0.66%
First Trust Large Cap Value Alphadex Fund
Proportion0.59%
Pacer Trendpilot US Mid Cap ETF
Proportion0.39%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
